Real-world safety of olaparib tracked in over 1,000 chinese cancer patients
NCT ID NCT04560452
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 23 times
Summary
This study tracked the safety of the drug olaparib in over 1,000 Chinese patients with ovarian or prostate cancer. Researchers recorded side effects and how doctors managed them in everyday practice. The goal was to better understand the drug's real-world safety profile in this population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Anhui, China
-
Research Site
Beijing, China
-
Research Site
Changsha, China
-
Research Site
Chengdu, China
-
Research Site
Chongqing, China
-
Research Site
Dongguan, China
-
Research Site
Foshan, China
-
Research Site
Fujian, China
-
Research Site
Guangdong, China
-
Research Site
Guangzhou, China
-
Research Site
Guangzho, China
-
Research Site
Guizhou, China
-
Research Site
Hangzhou, China
-
Research Site
He'nan, China
-
Research Site
Hebei, China
-
Research Site
Heilongjiang, China
-
Research Site
Henan, China
-
Research Site
Huizhou, China
-
Research Site
Jiangsu, China
-
Research Site
Jiangxi, China
-
Research Site
Jilin, China
-
Research Site
Jinghou, China
-
Research Site
Liaoning, China
-
Research Site
Luzhou, China
-
Research Site
Nanjing, China
-
Research Site
Nantong, China
-
Research Site
Ningbo, China
-
Research Site
Shandong, China
-
Research Site
Shanghai, China
-
Research Site
Shenyang, China
-
Research Site
Sichuan, China
-
Research Site
Taiyuan, China
-
Research Site
Tianjin, China
-
Research Site
Yichang, China
-
Research Site
Yunan, China
-
Research Site
Zhejiang, China
-
Research Site
Zhengzhou, China
Conditions
Explore the condition pages connected to this study.